Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Machine learning (ML) can predict a patient’s long-term risk of myocardial infarction (MI) or cardiac death, according to new findings published in Cardiovascular Research.
AI continues to evolve at a rapid pace, with new algorithms and solutions being developed all the time. What kind of long-term impact could these technologies have on patient care?
AI can identify women at a high risk of developing breast cancer more accurately than existing prediction models, according to a new study published in Radiology.
Machine learning (ML) algorithms can evaluate cardiac MR (CMR) images and provide accurate measurements of left ventricular (LV) volumes from throughout the patient’s cardiac cycle, according to a new study published in Magnetic Resonance Imaging.
Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.
The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals.
As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”
